Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Biolase, Inc. (NASDAQ: BIOL).

Full DD Report for BIOL

You must become a subscriber to view this report.


Recent News from (NASDAQ: BIOL)

Biolase Announces 1-for-5 Reverse Stock Split Common Stock Will Begin Trading On Split-Adjusted Basis On May 11
IRVINE, Calif. , May 10, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL) ("BIOLASE" or the "Company"), today announced that at its annual meeting of stockholders held on May 9, 2018 , the Company's stockholders granted the Board of Directors the discretion to effect a reverse stock...
Source: PR Newswire
Date: May, 10 2018 06:00
BIOLASE and Los Angeles Chargers Partner to Bring Advanced Dental Care to Children in Underserved Communities in Southern California
LOS ANGELES and IRVINE, Calif. , May 9, 2018 /PRNewswire/ --  BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and the Los Angeles Chargers today announced a partnership to bring advanced dental care to children in underserved communities in Southern California...
Source: PR Newswire
Date: May, 09 2018 08:00
Biolase's (BIOL) CEO John Beaver on Q1 2018 Results - Earnings Call Transcript
Biolase, Inc (NASDAQ:BIOL) Q1 2018 Earnings Conference Call May 2, 2018 4:30 PM ET Executives Rene Caron - Investor Relations John Beaver - Interim CEO, Senior Vice President and Chief Financial Officer Analysts Robert Maltbie - Singular Research Ed Woo - Ascendiant Capit...
Source: SeekingAlpha
Date: May, 02 2018 18:44
Biolase beats by $0.01, misses on revenue
Biolase (NASDAQ: BIOL ): Q1 EPS of -$0.04 beats by $0.01 . More news on: Biolase, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 02 2018 16:29
BIOLASE Reports 2018 First Quarter Results
IRVINE, Calif. , May 2, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today reported its financial results for its first quarter ended March 31, 2018 . Net revenue for the first quarter of 2018 was $10.0 million , an 8% decrease from the f...
Source: PR Newswire
Date: May, 02 2018 16:05
BIOLASE® To Host 2018 First Quarter Financial Results Conference Call On May 2, 2018
IRVINE, Calif. , April 25, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that the Company will host a conference call on Wednesday, May 2, 2018 , at 4:30 p.m. Eastern Time to discuss its operating results for the first qu...
Source: PR Newswire
Date: April, 25 2018 08:30
BIOLASE Establishes Southern California Dental Advisory Board
IRVINE, Calif. , April 17, 2018 /PRNewswire/ --  BIOLASE, Inc.  (NASDAQ: BIOL), the global leader in dental lasers, announced today the formation of its Southern California Dental Advisory Board. The newly formed Advisory Board will increase awareness around the minimally-invasi...
Source: PR Newswire
Date: April, 17 2018 08:00
BIOLASE Board Of Directors Asks Chairman Jonathan T. Lord, M.D. To Take On Expanded Leadership Role And Explore Strategic Options
IRVINE, Calif. , April 11, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the world's leading manufacturer and distributor of dental lasers and a pioneer in laser surgery in other medical specialties, today announced that its Board of Directors ("Board") has asked Jonathan T. Lord , M...
Source: PR Newswire
Date: April, 11 2018 08:00
BIOLASE Names Garrett Sato To Board Of Directors
IRVINE, Calif. , April 4, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it has named veteran dental industry and financial services executive Garrett Sato to its Board of Directors, effective immediately. The addition of...
Source: PR Newswire
Date: April, 04 2018 16:23
BIOLASE Announces Growing Awareness of Dental Lasers Among Pediatric Dentists, Demonstrating Shift Toward Pain-Free Dentistry
IRVINE, Calif. , March 28, 2018 /PRNewswire/ --  BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that the demand for pain-free care increases as awareness of the  more patient-friendly benefits of using dental lasers is growing in pediatric den...
Source: PR Newswire
Date: March, 28 2018 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-201.771.7951.881.7774,356
2018-08-171.951.78991.981.6113135,009
2018-08-161.651.951.951.611115,186
2018-08-151.501.64831.651.5066,699
2018-08-141.411.50991.541.30164,260

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-2019,41437,81651.3381Short
2018-08-1726,72355,81147.8812Short
2018-08-1620,45934,66459.0209Short
2018-08-159,23216,53755.8263Short
2018-08-1456,98779,13372.0142Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BIOL.


About Biolase, Inc. (NASDAQ: BIOL)

Logo for Biolase, Inc. (NASDAQ: BIOL)

Not available

 

Contact Information

 

 

Current Management

  • Jeffrey W. Jones / President, CEO
  • Stephen R. Tartamella / CFO

Current Share Structure

  • Issue and Outstanding: 20,476,048 - 05/11/2018

 


Recent Filings from (NASDAQ: BIOL)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 11 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 10 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: May, 10 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 04 2018
Amendment to a previously filed 8-K
Filing Type: 8-K/AFiling Source: edgar
Filing Date: May, 03 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 13 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 10 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 05 2018

 

 


Daily Technical Chart for (NASDAQ: BIOL)

Daily Technical Chart for (NASDAQ: BIOL)


Stay tuned for daily updates and more on (NASDAQ: BIOL)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: BIOL)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BIOL is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of BIOL and does not buy, sell, or trade any shares of BIOL. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/